• Publications
  • Influence
Administration of trimethoprim-sulphadimidine does not improve healing of glandular gastric ulceration in horses receiving omeprazole: a randomised, blinded, clinical study
BackgroundInterest in Equine Gastric Ulcer Syndrome (EGUS) has recently increased in part due to a growing awareness of the differences between squamous and glandular disease. The pathophysiology andExpand
  • 17
  • 4
  • PDF
A comparison of two doses of omeprazole in the treatment of equine gastric ulcer syndrome: a blinded, randomised, clinical trial.
REASONS FOR PERFORMING THE STUDY Studies on omeprazole have reported that doses as low as 0.7 mg/kg bwt per os are potent suppressors of acid production. Yet, to date, no studies have comparedExpand
  • 34
  • 1
A comparison between pre‐ and post exercise administration of omeprazole in the treatment of equine gastric ulcer syndrome: A blinded, randomised, clinical trial
Summary Reasons for performing the study A recent study suggested that the duration of acid suppression achieved with once-daily administration of omeprazole is as short as 12 h and thatExpand
  • 25
  • 1
Comparison of the effect of two doses of omeprazole on the squamous gastric mucosa in thoroughbred racehorses
Omeprazole is widely used as a prophylactic agent against gastric ulceration in the horse, and doses of buffered omeprazole at 1 mg/kg per os once a day have been shown to be effective (McClure andExpand
  • 7
  • 1
Efficacy of a Combination of Apolectol, Live Yeast (Saccharomyces cerevisiae [CNCM I-1077]), and Magnesium Hydroxide in the Management of Equine Gastric Ulcer Syndrome in Thoroughbred Racehorses: A
To date, prevention of equine gastric ulcer syndrome (EGUS) has relied on management changes or pharmaceutical agents. The identification of an alternative means of prevention would be useful.Expand
  • 9
  • 1
A comparison of three doses of omeprazole in the treatment of equine gastric ulcer syndrome: A blinded, randomised, dose-response clinical trial.
REASONS FOR PERFORMING THE STUDY A previous study demonstrated that a dose effect between 1.6 and 4.0 mg/kg bwt of omeprazole per os s.i.d. is present in the treatment of equine gastric ulceration.Expand
  • 39
Efficacy of a Combination of a Unique Pectin‐Lecithin Complex (Apolectol®), Live Yeast and Magnesium Hydroxide in the Prevention of EGUS and Faecal Acidosis in Thoroughbred Racehorses: A Randomised,
Aims To evaluate the efficacy of a combination of a unique pectin-lecithin complex (Apolectol®), live yeast and magnesium hydroxide in the prevention of equine gastric ulcer syndrome (EGUS) andExpand
  • 4